| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $101.2M | +90.4% |
| R&D Expense | $77.7M | -30.4% |
| SG&A Expense | $30.0M | -29.9% |
| Operating Income | -$6.5M | +93.6% |
| Pre-tax Income | $3.3M | +103.3% |
| Income Tax | $3.9M | — |
| Net Income | -$569K | +99.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.2M | -91.1% |
| Accounts Receivable | $3.4M | -90.5% |
| Current Assets | $182.9M | -22.8% |
| Total Assets | $201.8M | -22.7% |
| Current Liabilities | $155.9M | +2.2% |
| Total Liabilities | $249.2M | -28.1% |
| Stockholders' Equity | -$47.4M | +44.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.0M | +49.4% |
| Capital Expenditures | $840K | -51.7% |
| Investing Cash Flow | -$150.7M | -253.3% |
| Financing Cash Flow | $30.2M | +4565.1% |
| Free Cash Flow | -$56.9M | +49.5% |